000 01383 a2200397 4500
005 20250514181529.0
264 0 _c20040624
008 200406s 0 0 eng d
022 _a0315-162X
040 _aNLM
_beng
_cNLM
100 1 _aBrandt, Jan
245 0 0 _aSuccessful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
_h[electronic resource]
260 _bThe Journal of rheumatology
_cMar 2004
300 _a531-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aEtanercept
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReceptors, Tumor Necrosis Factor
_xtherapeutic use
650 0 4 _aRecombinant Fusion Proteins
_xtherapeutic use
650 0 4 _aSpondylitis
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aKhariouzov, Andre
700 1 _aListing, Joachim
700 1 _aHaibel, Hildrun
700 1 _aSörensen, Helmut
700 1 _aRudwaleit, Martin
700 1 _aSieper, Joachim
700 1 _aBraun, Jurgen
773 0 _tThe Journal of rheumatology
_gvol. 31
_gno. 3
_gp. 531-8
999 _c14714914
_d14714914